These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38316002)

  • 1. In persons aged ≥45 y, the mt-sRNA test had 94% sensitivity for colorectal cancer and 46% for advanced adenomas.
    Murff HJ
    Ann Intern Med; 2024 Feb; 177(2):JC23. PubMed ID: 38316002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multitarget Stool RNA Test for Colorectal Cancer Screening.
    Barnell EK; Wurtzler EM; La Rocca J; Fitzgerald T; Petrone J; Hao Y; Kang Y; Holmes FL; Lieberman DA
    JAMA; 2023 Nov; 330(18):1760-1768. PubMed ID: 37870871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of multitarget stool DNA testing in African American patients.
    Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L
    Cancer; 2018 Oct; 124(19):3876-3880. PubMed ID: 30193399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Review of Multitarget Stool DNA as a Screening Test for Colorectal Cancer.
    Kleinschmidt TK; Clements A; Parker MA; Scarcliff SD
    Am Surg; 2023 Apr; 89(4):603-606. PubMed ID: 34278822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
    Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
    Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
    Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
    Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of multitarget stool DNA testing for colorectal cancer screening: A systematic review and meta-analysis.
    Dolatkhah R; Dastgiri S; Jafarabadi MA; Abdolahi HM; Somi MH
    Gastroenterol Hepatol; 2022 Dec; 45(10):753-766. PubMed ID: 35101601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Referral Rates for Genetic Assessment of Patients With Multiple Adenomas in United Kingdom Bowel Cancer Screening Programs.
    Alexander JL; Johnston BJ; Smith TJ; Yong KK; Marshall SM; Fawkes JDC; Martin JP; Seward EW; Saunders B; Monahan KJ
    Dis Colon Rectum; 2021 Sep; 64(9):1058-1063. PubMed ID: 34039904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
    Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
    Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening.
    Johnson DH; Kisiel JB; Burger KN; Mahoney DW; Devens ME; Ahlquist DA; Sweetser S
    Gastrointest Endosc; 2017 Mar; 85(3):657-665.e1. PubMed ID: 27884518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
    N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
    N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
    Hundt S; Haug U; Brenner H
    Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
    Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
    Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.
    Zou H; Taylor WR; Harrington JJ; Hussain FT; Cao X; Loprinzi CL; Levine TR; Rex DK; Ahnen D; Knigge KL; Lance P; Jiang X; Smith DI; Ahlquist DA
    Gastroenterology; 2009 Feb; 136(2):459-70. PubMed ID: 19026650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent detection rates of fecal immunochemical test and questionnaire-based risk assessment for detecting proximal and distal advanced colorectal adenomas.
    Chen HD; Lu M; Zhang YH; Dai M
    Chin Med J (Engl); 2021 Jan; 134(5):605-607. PubMed ID: 33410637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.